Lantern Pharma, Inc. (LTRN)
4.06
+0.18
(+4.64%)
USD |
NASDAQ |
Jun 11, 16:00
4.06
0.00 (0.00%)
After-Hours: 16:06
Lantern Pharma Accounts Payable (Quarterly) : 3.718M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 3.718M |
| December 31, 2025 | 4.423M |
| September 30, 2025 | 3.946M |
| June 30, 2025 | 4.753M |
| March 31, 2025 | 4.125M |
| December 31, 2024 | 4.140M |
| September 30, 2024 | 3.404M |
| June 30, 2024 | 4.437M |
| March 31, 2024 | 3.775M |
| December 31, 2023 | 2.505M |
| September 30, 2023 | 2.085M |
| June 30, 2023 | 2.853M |
| March 31, 2023 | 2.674M |
| Date | Value |
|---|---|
| December 31, 2022 | 2.745M |
| September 30, 2022 | 3.047M |
| June 30, 2022 | 5.174M |
| March 31, 2022 | 2.919M |
| December 31, 2021 | 2.174M |
| September 30, 2021 | 1.637M |
| June 30, 2021 | 1.094M |
| March 31, 2021 | 0.6645M |
| December 31, 2020 | 0.5523M |
| September 30, 2020 | 0.8146M |
| June 30, 2020 | 0.459M |
| March 31, 2020 | 0.4483M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Replimune Group, Inc. | 5.647M |
| Arrowhead Pharmaceuticals, Inc. | 30.75M |
| Oncolytics Biotech, Inc. | 0.00 |
| Sangamo Therapeutics, Inc. | 19.31M |
| Sarepta Therapeutics, Inc. | 70.38M |